The Infections and Immunoepidemiology Branch (IIB) in the intramural Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is recruiting a tenure-track/tenure-eligible position with a research focus on the epidemiology of cancer in relation to infections and/or immune variation. The applicant is expected to have research expertise and experience incorporating state-of-the-art laboratory methods to assess infections and/or immunity in epidemiologic studies of human populations. Relevant biomarkers include (but are not limited to): detection of microbial DNA, RNA, or proteins; antibody profiles or T-cell reactivity against infectious agents or other antigens; circulating immune cell subsets and immune-related proteins; checkpoint proteins and other systemic/tissue markers of immune evasion; and germline or somatic immunogenetics.
IIB conducts epidemiologic research on the contribution of infections and immune variation to the development of cancer. The branch focuses on etiologic and natural history studies with potential translation for cancer prevention, risk stratification, screening, and clinical medicine. Topics of special interest include oncogenic infections and immune responses to such infections; immune-related disorders, e.g., HIV infection, transplantation, and autoimmune diseases; chronic inflammation; the role of immunosurveillance and immune evasion in progression of premalignant lesions; and normal or subclinical immune variation, e.g., due to host genetics or immunosenescence. Ongoing research includes international population-based cohort and case-control studies of cancer, a series of human papillomavirus vaccine trials, and registry linkage studies of HIV infection and transplantation. IIB investigators utilize data and biospecimens from a large collection of prior field studies conducted by branch members and outside researchers. DCEG is currently launching a multicenter US cohort study that will provide additional epidemiologic research opportunities.
Applicants for this tenure track/tenure-eligible position will be evaluated on their prospects to develop a creative and independent research program in the epidemiology and natural history of infections and/or immune variation, especially with regards to the potential to uncover mechanisms underlying the development of cancer in humans. Applicants should have an MD degree or doctorate in epidemiology, immunology, virology, or related field. A demonstrated ability to lead effective collaborations with investigators from different disciplines is critical. The candidate is expected to have strong written and verbal communication skills. Also essential is the ability to produce high-impact research, as demonstrated in grant funding, presentations, and/or publications.
Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. NIH encourages the application and nomination of qualified women, minorities and individuals with disabilities. NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis. This position is subject to a background investigation. Salary is commensurate with research experience.
Interested individuals should send a cover letter, curriculum vitae and bibliography. Please include a description of your mentoring and outreach activities, especially those involving women and persons from groups that are underrepresented in biomedical research. In addition, please include a brief summary of research experience, accomplishments, and research interests and goals; copies of three publications or preprints; and three letters of reference. Application materials should be sent to:
Dr. Kelly Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute
9609 Medical Center Drive, Suite 6E226, MSC 9775
Bethesda, MD 20892-9775
The review of applications will begin on or about November 1, 2020, but applications will be accepted until the position is filled.
Please contact Dr. Eric Engels by phone 240-276-7186 or email at firstname.lastname@example.org for questions about the position.
DHHS, NIH, and NCI are Equal Opportunity Employers